Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates

ClinicalTrials.gov ID: NCT02074059

Public ClinicalTrials.gov record NCT02074059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Open-Label, Controlled Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Preterm Neonates 29 to 34 Weeks PMA: Dose Escalation and Study Extension

Study identification

NCT ID
NCT02074059
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Windtree Therapeutics
Industry
Enrollment
80 participants

Conditions and interventions

Interventions

  • Lucinactant for Inhalation Drug
  • nCPAP alone Device

Drug · Device

Eligibility (public fields only)

Age range
29 Weeks to 34 Weeks
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2014
Primary completion
Sep 30, 2015
Completion
Oct 31, 2015
Last update posted
Apr 20, 2017

2014 – 2015

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35249
Arkansas Children's Hospital Little Rock Arkansas 72202
Loma Linda University Medical Center Loma Linda California 92354
Sharp Mary Birch Hospital for Women and Newborns San Diego California 92123
Christiana Care Health System Newark Delaware 19713
University of Miami Miami Florida 33136
Riley Hospital for Children at IU Health Indianapolis Indiana 46202
University of Louisville Louisville Kentucky 40202
Mid Atlantic Neonatology Associates Morristown New Jersey 07960
Duke University Medical Center Durham North Carolina 27710
Providence St. Vincent Medical Center Portland Oregon 97225

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02074059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02074059 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →